Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Tanabe Pharma America, Inc.
Travera Inc
Turning Point Therapeutics, Inc.
Hoffmann-La Roche
Travera Inc
UNICANCER
Xencor, Inc.